Uncategorized

FDA approves Lilly obesity pill, triggering battle with Novo Nordisk

Published

on

Foundayo could erase the Wegovy pill’s four-month head start as the two drugmakers clash on a debate of efficacy and convenience.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version